Koller M - Search Results

1

Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use.

Werner M, Pervan P, Glück V, Zeman F, Koller M, Burkhardt R, Glück T, Wenzel JJ, Schmidt B, Gessner A, Peterhoff D. Werner M, et al. Among authors: koller m. J Clin Med. 2021 Apr 8;10(8):1580. doi: 10.3390/jcm10081580. J Clin Med. 2021. PMID: 33918081 Free PMC article.

2

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.

Glück V, Grobecker S, Köstler J, Tydykov L, Bertok M, Weidlich T, Gottwald C, Salzberger B, Wagner R, Zeman F, Koller M, Gessner A, Schmidt B, Glück T, Peterhoff D. Glück V, et al. Among authors: koller m. Infection. 2022 Apr;50(2):439-446. doi: 10.1007/s15010-021-01703-9. Epub 2021 Sep 25. Infection. 2022. PMID: 34562263 Free PMC article.

3

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.

Glück V, Tydykov L, Mader AL, Warda AS, Bertok M, Weidlich T, Gottwald C, Köstler J, Salzberger B, Wagner R, Koller M, Gessner A, Schmidt B, Glück T, Peterhoff D. Glück V, et al. Among authors: koller m. Infection. 2022 Dec;50(6):1475-1481. doi: 10.1007/s15010-022-01817-8. Epub 2022 Apr 11. Infection. 2022. PMID: 35403960 Free PMC article.

4

A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.

Peterhoff D, Glück V, Vogel M, Schuster P, Schütz A, Neubert P, Albert V, Frisch S, Kiessling M, Pervan P, Werner M, Ritter N, Babl L, Deichner M, Hanses F, Lubnow M, Müller T, Lunz D, Hitzenbichler F, Audebert F, Hähnel V, Offner R, Müller M, Schmid S, Burkhardt R, Glück T, Koller M, Niller HH, Graf B, Salzberger B, Wenzel JJ, Jantsch J, Gessner A, Schmidt B, Wagner R. Peterhoff D, et al. Among authors: koller m. Infection. 2021 Feb;49(1):75-82. doi: 10.1007/s15010-020-01503-7. Epub 2020 Aug 21. Infection. 2021. PMID: 32827125 Free PMC article.

5

Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma-An Analysis of a Certified Tumor Registry over 17 Years.

Prantl L, Gerken M, Zeman F, Leitzmann M, Koller M, Klinkhammer-Schalke M, Evert M, Kuehlmann B, Biermann N. Prantl L, et al. Among authors: koller m. J Clin Med. 2020 Apr 25;9(5):1247. doi: 10.3390/jcm9051247. J Clin Med. 2020. PMID: 32344893 Free PMC article.

6

Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020.

Bauernfeind S, Hitzenbichler F, Huppertz G, Zeman F, Koller M, Schmidt B, Plentz A, Bauswein M, Mohr A, Salzberger B. Bauernfeind S, et al. Among authors: koller m. Infection. 2021 Dec;49(6):1307-1311. doi: 10.1007/s15010-021-01622-9. Epub 2021 May 20. Infection. 2021. PMID: 34014530 Free PMC article.

7

Macular hole surgery: an analysis of risk factors for the anatomical and functional outcomes with a special emphasis on the experience of the surgeon.

Jenisch TM, Zeman F, Koller M, Märker DA, Helbig H, Herrmann WA. Jenisch TM, et al. Among authors: koller m. Clin Ophthalmol. 2017 Jun 13;11:1127-1134. doi: 10.2147/OPTH.S125561. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28652700 Free PMC article.

8

Fractional carbon dioxide laser resurfacing of rhytides and photoaged skin--a prospective clinical study on patient expectation and satisfaction.

Kohl E, Meierhöfer J, Koller M, Zeman F, Groesser L, Karrer S, Hohenleutner U, Landthaler M, Hohenleutner S. Kohl E, et al. Among authors: koller m. Lasers Surg Med. 2015 Feb;47(2):111-9. doi: 10.1002/lsm.22326. Epub 2015 Feb 4. Lasers Surg Med. 2015. PMID: 25652114

9

Fractional carbon dioxide laser resurfacing of skin grafts: long-term results of a prospective, randomized, split-scar, evaluator-blinded study.

Datz E, Schönberger C, Zeman F, Koller M, Berneburg M, Landthaler M, Karrer S, Hohenleutner U, Hohenleutner S. Datz E, et al. Among authors: koller m. Lasers Surg Med. 2018 Dec;50(10):1010-1016. doi: 10.1002/lsm.22950. Epub 2018 Jun 17. Lasers Surg Med. 2018. PMID: 29911321 Clinical Trial.

10

TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.

Andorfer KEC, Seebauer CT, Koller M, Zeman F, Berneburg M, Fischer R, Vielsmeier V, Bohr C, Kühnel TS. Andorfer KEC, et al. Among authors: koller m. Clin Hemorheol Microcirc. 2022;80(3):307-315. doi: 10.3233/CH-211253. Clin Hemorheol Microcirc. 2022. PMID: 34864649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,156 results

Search Page